184 related articles for article (PubMed ID: 18701209)
1. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8.
Neurauter G; Grahmann AV; Klieber M; Zeimet A; Ledochowski M; Sperner-Unterweger B; Fuchs D
Cancer Lett; 2008 Dec; 272(1):141-7. PubMed ID: 18701209
[TBL] [Abstract][Full Text] [Related]
2. Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy.
Zangerle R; Kurz K; Neurauter G; Kitchen M; Sarcletti M; Fuchs D
Brain Behav Immun; 2010 Mar; 24(3):403-8. PubMed ID: 19925861
[TBL] [Abstract][Full Text] [Related]
3. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations.
Ploder M; Neurauter G; Spittler A; Schroecksnadel K; Roth E; Fuchs D
Amino Acids; 2008 Aug; 35(2):303-7. PubMed ID: 18163176
[TBL] [Abstract][Full Text] [Related]
4. Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations.
Wissmann P; Geisler S; Leblhuber F; Fuchs D
J Neurol Sci; 2013 Jun; 329(1-2):29-33. PubMed ID: 23566485
[TBL] [Abstract][Full Text] [Related]
5. Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis.
Birk D; Gansauge F; Gansauge S; Schwarz A; Beger HG
Eur J Med Res; 1999 Apr; 4(4):156-60. PubMed ID: 10205291
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
Weinlich G; Murr C; Richardsen L; Winkler C; Fuchs D
Dermatology; 2007; 214(1):8-14. PubMed ID: 17191041
[TBL] [Abstract][Full Text] [Related]
7. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
[TBL] [Abstract][Full Text] [Related]
8. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
Buchwald D; Wener MH; Pearlman T; Kith P
J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
10. Neopterin in HIV-1 infection.
Wirleitner B; Schroecksnadel K; Winkler C; Fuchs D
Mol Immunol; 2005 Feb; 42(2):183-94. PubMed ID: 15488607
[TBL] [Abstract][Full Text] [Related]
11. Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer.
Schroecksnadel K; Frick B; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2006 Aug; 240(2):198-202. PubMed ID: 16271434
[TBL] [Abstract][Full Text] [Related]
12. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?
Murr C; Fuith LC; Widner B; Wirleitner B; Baier-Bitterlich G; Fuchs D
Anticancer Res; 1999; 19(3A):1721-8. PubMed ID: 10470106
[TBL] [Abstract][Full Text] [Related]
13. Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy.
Ranjan P; Gupta A; Kumar S; Gowda GA; Ranjan A; Sonker AA; Chandra A; Ramakant
Liver Int; 2006 Aug; 26(6):703-7. PubMed ID: 16842327
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of ceruloplasmin activity in oncogynecological diseases].
Gusarova IuN; Stepanova EV; Landesman EO; Koroleva OV; Vavilova TP; Makarov OV; Kosetskiĭ VN
Vopr Med Khim; 2002; 48(4):388-93. PubMed ID: 12506616
[TBL] [Abstract][Full Text] [Related]
15. Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column.
Lentz M; Kumar K
Ther Apher Dial; 2008 Dec; 12(6):491-9. PubMed ID: 19140848
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
[TBL] [Abstract][Full Text] [Related]
18. Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers.
Stratigos AJ; Malanos D; Touloumi G; Antoniou A; Potouridou I; Polydorou D; Katsambas AD; Whitby D; Mueller N; Stratigos JD; Hatzakis A
Arch Dermatol; 2005 Nov; 141(11):1421-6. PubMed ID: 16301389
[TBL] [Abstract][Full Text] [Related]
19. Soluble Receptors for Tumor Necrosis Factor and Neopterin as Parameters of Cell-Mediated Immune Activation.
Tilz GP; Diez-Ruiz A; Baier-Bitterlich G; Demel U; Wachter H; Fuchs D
Hematology; 1996; 1(2):141-54. PubMed ID: 27406429
[TBL] [Abstract][Full Text] [Related]
20. Significance of serum tumor markers in patients with carcinoma of the ovary.
Kikuchi Y; Kizawa I; Koyama E; Kato K
Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
